Literature DB >> 6083502

The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.

S M Jancsár, B E Leonard.   

Abstract

The effects of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory bulbectomized (OB) rat and on the levels of some central neurotransmitters were investigated. The reversal of hyperactivity by racemic mianserin was found to be independent of dose within a non-sedative range of 2-10 mg/kg and occurred following seven days of treatment. Chronic administration of racemic mianserin, over the dose range 2-15 mg/kg elevated the steady-state concentration of noradrenaline in the amygdaloid cortex and midbrain. Of the two enantiomers, only the behaviourally active (+)-(S)-form increased the steady state concentration of noradrenaline in these two areas of the brain. The reversal of the hyperactivity by (+/-)mianserin and the (+)-(S)-enantiomer was not associated with a change in the concentration of serotonin or 5-hydroxyindole acetic acid. The behaviourally inactive enantiomer (-)-(R) decreased the concentration of 5-hydroxyindole acetic acid, an effect which may be associated with the sedative action of the drug. The results suggest that the reversal of the behavioural hyperactivity of the olfactory bulbectomized (OB) rat by (+/-)mianserin and its (+)-(S)-enantiomer is associated with an increase in the steady-state concentration of noradrenaline, in the areas of the brain studied.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6083502     DOI: 10.1016/0028-3908(84)90130-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.

Authors:  Magdalena Jastrzębska-Więsek; Agata Siwek; Anna Partyka; Bernadeta Szewczyk; Magdalena Sowa-Kućma; Anna Wasik; Marcin Kołaczkowski; Anna Wesołowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-16       Impact factor: 3.000

Review 2.  The recent progress in animal models of depression.

Authors:  Qingzhong Wang; Matthew A Timberlake; Kevin Prall; Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-08       Impact factor: 5.067

3.  Strain differences in the distribution of N-methyl-d-aspartate and gamma (gamma)-aminobutyric acid-A receptors in rat brain.

Authors:  Yanlin Lei; Irene Yaroslavsky; Shanaz M Tejani-Butt
Journal:  Life Sci       Date:  2009-10-27       Impact factor: 5.037

4.  Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.

Authors:  T H Hand; G J Marek; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Chirality and drugs used in psychiatry: nice to know or need to know?

Authors:  R M Lane; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

6.  Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.

Authors:  María Belén Poretti; Rahul S Sawant; Mathias Rask-Andersen; Marta Fiol de Cuneo; Helgi B Schiöth; Mariela F Perez; Valeria Paola Carlini
Journal:  Psychopharmacology (Berl)       Date:  2015-12-23       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.